Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer
Jean Bourhis, Alexander Stein, Jan Paul de Boer, Marc Van den Eynde, Kathryn A. Gold, Sebastian Stintzing, Jürgen C. Becker, Michael Moran, Andreas Schröeder, Gregory Pennock, Satu Salmio, Regina Esser, Fortunato Ciardiello
Topics & Concepts
CetuximabAvelumabMedicineMerkel cell carcinomaImmunogenic cell deathCancer researchAntibody-dependent cell-mediated cytotoxicityEpidermal growth factor receptorImmunotherapyImmune systemImmunologyCancerOncologyMonoclonal antibodyAntibodyInternal medicineCarcinomaNivolumabPolyomavirus and related diseasesImmune Cell Function and InteractionCAR-T cell therapy research